Clinical Trial Update: Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

This item reports the status of a Phase 2 trial evaluating fenretinide in patients with recurrent or metastatic ovarian epithelial cancer and primary peritoneal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Fenretinide (fenretinide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer | Phase 2 | Status: COMPLETED